Epstein-linked longevity guru Peter Attia leaves David Protein, and his own startup ‘makes no comment’ | TechCrunch

The founder of David Protein, maker of popular high-protein nutrition bars, announced on X on Monday that longevity guru is Dr. Peter Attia “stepped down from his role as Chief Science Officer at David.”

The announcement comes after Attia’s name appeared in more than 1,700 documents, including email correspondence, released Friday as part of a massive file dump involving convicted sex offender Jeffrey Epstein. according to The New York Times. Attia was a member of the food startup’s executive team and was also a early investor.

For those unfamiliar, Attia is a Canadian-American physician who has become one of the most prominent voices in the field of longevity and preventative health. He is best known for his best-selling book “Outlive: The Science and Art of Longevity” and his now seven-year-old podcast, in which he explores optimization strategies. He was also hired as an employee at CBS last month.

Three-year-old New York-based David Protein raised a $75 million Series A funding round led by Greenoaks in May last year, with participation from Valor Equity Partners. The company has experienced significant growth since launching its flagship protein bar in September 2024, a product it claims contains 28 grams of protein, zero sugar and 150 calories.

In a long-term message on XAttia wrote that he was “ashamed” of some of the crude content of his emails with Epstein, but he also said he was not involved in criminal activity and had never visited Epstein’s island or traveled on his plane. Attia also discussed at length how he met Epstein and why he remained involved with him even after Epstein’s death. Conviction from 2008.

The consequences appear to extend beyond David Protein. It also appears that Biograph, the healthcare testing and longevity startup that Attia co-founded with entrepreneur John Hering, is distancing itself from the doctor. The company declined to comment on Attia’s continued participation in the startup or on the pages on its website that used to list him but now omit his name or return a “file not found” error.

Biograph emerged from stealth a year ago, TechCrunch previously reported, with backing from investors like Vy Capital, Human Capital, Alpha Wave and WndrCo, along with angel investors including Balaji Srinivasan. Like a growing number of concierge medical services providers, Biograph offers premium preventative health services to subscribers who pay between $7,500 and $15,000 per year. Attia was previously mentioned on the company press release and site as co-founder.